Eisai Co Ltd (ESAIY)
10.78
+0.17
(+1.60%)
USD |
OTCM |
May 09, 15:59
Eisai Revenue (Quarterly): 1.330B for Dec. 31, 2022
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 1.330B |
| September 30, 2022 | 1.262B |
| June 30, 2022 | 1.422B |
| March 31, 2022 | 1.643B |
| December 31, 2021 | 1.786B |
| September 30, 2021 | 1.485B |
| June 30, 2021 | 1.817B |
| March 31, 2021 | 1.394B |
| December 31, 2020 | 1.736B |
| September 30, 2020 | 1.427B |
| June 30, 2020 | 1.539B |
| March 31, 2020 | 1.924B |
| December 31, 2019 | 1.718B |
| September 30, 2019 | 1.354B |
| June 30, 2019 | 1.401B |
| March 31, 2019 | 1.594B |
| December 31, 2018 | 1.394B |
| September 30, 2018 | 1.407B |
| June 30, 2018 | 1.406B |
| March 31, 2018 | 1.477B |
| December 31, 2017 | 1.371B |
| September 30, 2017 | 1.291B |
| June 30, 2017 | 1.277B |
| March 31, 2017 | 1.142B |
| December 31, 2016 | 1.277B |
| Date | Value |
|---|---|
| September 30, 2016 | 1.299B |
| June 30, 2016 | 1.268B |
| March 31, 2016 | 1.054B |
| December 31, 2015 | 1.243B |
| September 30, 2015 | 1.115B |
| June 30, 2015 | 1.148B |
| March 31, 2015 | 1.175B |
| December 31, 2014 | 1.219B |
| September 30, 2014 | 1.311B |
| June 30, 2014 | 1.300B |
| March 31, 2014 | 1.501B |
| December 31, 2013 | 1.401B |
| September 30, 2013 | 1.533B |
| June 30, 2013 | 1.548B |
| March 31, 2013 | 1.543B |
| December 31, 2012 | 1.763B |
| September 30, 2012 | 1.800B |
| June 30, 2012 | 1.833B |
| March 31, 2012 | 1.808B |
| December 31, 2011 | 2.245B |
| September 30, 2011 | 2.106B |
| June 30, 2011 | 2.050B |
| March 31, 2011 | 1.885B |
| December 31, 2010 | 2.440B |
| September 30, 2010 | 2.418B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.262B
Minimum
Sep 2022
1.924B
Maximum
Mar 2020
1.549B
Average
1.485B
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Biogen Inc | 2.290B |
| Takeda Pharmaceutical Co Ltd | 7.526B |
| Nxera Pharma Co Ltd | 49.39M |
| PeptiDream Inc | 41.78M |
| Stemcell Holdings Inc | 3.403M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 61.31M |
| Total Expenses (Quarterly) | 1.270B |
| EPS Diluted (Quarterly) | 0.2138 |